INMED PHARMACEUTICALS INC. (INM) Total liabilities 2021–2025
INMED PHARMACEUTICALS INC. (INM) total liabilities at each fiscal year-end, per SEC filings.
$2.1MFY2025 · since FY2021: $2.4M → $2.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1M | -18.0% |
| FY2024 | $2.6M | +29.8% |
| FY2023 | $2.0M | -45.6% |
| FY2022 | $3.7M | +54.2% |
| FY2021 | $2.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice